The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

For women who undergo a mastectomy, reconstruction is treated almost as a given. We speaks to seven women proudly defying the status quo.

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

A genetic screening test can be a powerful tool for understanding your inherited risk of developing certain diseases.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients ...

An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score ...

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

A new Australian artificial intelligence tool could transform breast cancer screening by offering a more personalised and ...

In the United States, breast cancer is the most common cancer diagnosed among women. In Texas, more than 22,000 women were expected to be diagnosed with breast cancer in 2025, according to the Texas ...